Acarbose

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

14 Suppliers, 9 USDMF, 6 CEP/COS, 3 JDMF, 2 KDMF, 6 NDC API, 7 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

97 Dossiers, 27 FDA Orange Book, 33 Europe, 4 Canada, 6 Australia, 2 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 14 Roquette, 9 Sigachi Industries, 7 Microlex e.U, 7 Gangwal Healthcare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 SPI Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Kerry, 4 Gangwal Chemicals, 3 DFE Pharma, 3 Prachin Chemical, 3 Ingredion Pharma Solutions, 3 Vasa Pharmachem, 1 Ideal Cures Pvt Ltd, 1 Jai Radhe Sales, 1 Pharmatrans-Sanaq, 1 Seppic

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders, 18 Disintegrants & Superdisintegrants, 16 Direct Compression, 11 Lubricants & Glidants, 11 Thickeners and Stabilizers, 8 Granulation, 8 Co-Processed Excipients, 5 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 5 Taste Masking, 3 Coating Systems & Additives, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Film Formers & Plasticizers

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 37 Finished Drug Prices

MARKET PLACE

12 APIs, 1 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

4 News

4 News

Information, Expiry & Status of Health Canada Patents covering Acarbose.

Acarbose

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

14 Suppliers

9 USDMF

6 CEP/COS

3 JDMF

2 KDMF

6 NDC API

7 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

97 Dossiers

27 FDA Orange Book

33 Europe

4 Canada

6 Australia

2 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

14 Roquette

9 Sigachi Industries

7 Microlex e.U

7 Gangwal Healthcare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 SPI Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Kerry

4 Gangwal Chemicals

3 DFE Pharma

3 Prachin Chemical

3 Ingredion Pharma Solutions

3 Vasa Pharmachem

1 Ideal Cures Pvt Ltd

1 Jai Radhe Sales

1 Pharmatrans-Sanaq

1 Seppic

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders

18 Disintegrants & Superdisintegrants

16 Direct Compression

11 Lubricants & Glidants

11 Thickeners and Stabilizers

8 Granulation

8 Co-Processed Excipients

5 Controlled & Modified Release

5 Chewable & Orodispersible Aids

5 Taste Masking

3 Coating Systems & Additives

2 Rheology Modifiers

2 Emulsifying Agents

1 API Stability Enhancers

1 Film Formers & Plasticizers

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions

37 Finished Drug Prices

MARKET PLACE

12 APIs

1 DOSSIERS // FDF

PATENTS

2 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards

2 USP Standards

2 Other Ref. Standards

DIGITAL CONTENT

4 News

Acarbose

Acarbose

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons